Published Date: 17 Feb 2023
Bhopal: Over 10,000...
Read Full NewsTelemedicine use is not associated with a substantial increase in mental health treatment among patients in rural, low-access, or distant communities, a new study shows.
A new analysis explores whether accelerating RT delivery with 6 fractions vs 5 fractions per week improves outcomes in patients with locally advanced HNSCC receiving concurrent chemotherapy.
Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or immunotherapeutic payload to cancer cells.
A population-based cohort study finds that an increased use of adjuvant systemic therapy can improve survival in patients with metachronous and synchronous bilateral breast cancer.
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
Immunotherapy in Head and Neck Cancer After Failure of Definitive Therapy.
3.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
4.
In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.
5.
Best foot forward—chemo care should include podiatry, say researchers
1.
Everything You Need to Know About the Latest Hyponatremia Algorithm
2.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
3.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
4.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
5.
AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Current Scenario of Cancer- The Incidence of Cancer in Men
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation